Novel therapeutics targeting stress granules for C9ORF72-mediated ALS
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110082
- Recipient
-
Mayo Clinic Jacksonville (A Nonprofit Corporation) UEI GKPBCFV1QMM3 Part of Mayo Clinic
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $458,516
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Jacksonville, FL 32224, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded a $458,516 Project Grant to Mayo Clinic Jacksonville to support research titled "NOVEL THERAPEUTICS TARGETING STRESS GRANULES FOR C9ORF72-MEDIATED ALS." The grant period runs from February 1, 2021 through June 30, 2022.
The grant supports research into novel therapeutics targeting stress granules for the treatment of amyotrophic lateral sclerosis (ALS) caused by mutations in the C9orf72 gene. This work falls under the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health through innovative medical research solutions for battlefield injuries and other conditions. Dr. Scott Lynch of Mayo Clinic Jacksonville will lead the research efforts to investigate medical solutions for ALS, in line with the program's goals.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$323,984 | |
| Amendment | $0 | |
| Original award | $782,500 |
Quick answers
Who received award W81XWH2110082?
W81XWH2110082 was awarded to Mayo Clinic Jacksonville (A Nonprofit Corporation) by Defense Health Agency (Department of Defense) on February 1, 2021.
How much is award W81XWH2110082 worth?
$458,516 has been obligated on W81XWH2110082.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award